Retirement
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
Break down the concept of RMDs, their rules, current age thresholds, and practical tips like Roth conversions for managing tax implications.
-
The $1,500-a-Year GLP-1 Drug Threat to Retirement Savings
Half of GLP-1 users face choosing medication over retirement savings as out-of-pocket costs top $1,500 annually.
-
State Tax Policies on IRA Withdrawals Shape Retirement Savings for Seniors
Differences in state-level tax treatments on IRA withdrawals can significantly affect a retiree’s long-term financial stability, as seen in Arizona and Nevada.
-
Medicare Advantage Agents Earn Up to $725 per Enrollment While Original Medicare Pays Nothing
Federal caps allow agents to earn hundreds for Medicare Advantage sign-ups while paying nothing for Original Medicare recommendations.
-
Motley Fool Columnist Predicts AI Stock Bubble Will Burst, Citing Four Warning Signs
WASHINGTON, July 6 — A new Treasury Department report is warning that the artificial intelligence stock frenzy could end badly for everyday…
-
Retiree Past 70.5 With $500,000 Seeks Advice on Unwanted RMDs
The math on a forced withdrawal is simple enough. The Internal Revenue Service says you must take it. You take it. But…
-
State pensioners living alone warned they need to find extra £500
MANILA, June 27 — For families across the region with loved ones living alone in the UK, a quiet financial shift is…
-
Pension expert says retirees must review finances annually as costs rise £500
Claire Trott has a blunt message for anyone who thinks a state pension is a set-it-and-forget-it plan. It is not. The Head…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
How Major Medical Centers Partner With Tech Firms for Next-Gen Proton Therapy
-
FDA Denies Approval for Summit Therapeutics’ Ivonescimab in Lung Cancer
-
How will the next era of precision thoracic oncology change treatment choices for lung‑cancer patients?
-
FDA Approval Moves Astellas’ Padcev Into Curative Bladder Cancer Setting
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992















